BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11962492)

  • 1. Type-1 steroid 5 alpha-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5 alpha-reductase.
    Gerst C; Dalko M; Pichaud P; Galey JB; Buan B; Bernard BA
    Exp Dermatol; 2002 Feb; 11(1):52-8. PubMed ID: 11962492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss.
    Sánchez P; Serrano-Falcón C; Torres JM; Serrano S; Ortega E
    Arch Dermatol Res; 2018 Jan; 310(1):77-83. PubMed ID: 29185104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro.
    Asada Y; Sonoda T; Ojiro M; Kurata S; Sato T; Ezaki T; Takayasu S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2875-80. PubMed ID: 11397903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
    Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL
    J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles.
    Hoffmann R; Happle R
    Arch Dermatol Res; 1999; 291(2-3):100-3. PubMed ID: 10195397
    [No Abstract]   [Full Text] [Related]  

  • 6. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    Negri-Cesi P; Colciago A; Poletti A; Motta M
    Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro.
    Smith CM; Ballard SA; Worman N; Buettner R; Masters JR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1361-6. PubMed ID: 8636334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II.
    Makridakis NM; di Salle E; Reichardt JK
    Pharmacogenetics; 2000 Jul; 10(5):407-13. PubMed ID: 10898110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols.
    Hiipakka RA; Zhang HZ; Dai W; Dai Q; Liao S
    Biochem Pharmacol; 2002 Mar; 63(6):1165-76. PubMed ID: 11931850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methyl esters of N-(dicyclohexyl)acetyl-piperidine-4-(benzylidene-4-carboxylic acids) as drugs and prodrugs: a new strategy for dual inhibition of 5 alpha-reductase type 1 and type 2.
    Streiber M; Picard F; Scherer C; Seidel SB; Hartmann RW
    J Pharm Sci; 2005 Mar; 94(3):473-80. PubMed ID: 15627259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells.
    Thornton MJ; Laing I; Hamada K; Messenger AG; Randall VA
    Clin Endocrinol (Oxf); 1993 Dec; 39(6):633-9. PubMed ID: 8287580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory activities of some traditional Chinese herbs against testosterone 5α-reductase and effects of Cacumen platycladi on hair re-growth in testosterone-treated mice.
    Zhang B; Zhang RW; Yin XQ; Lao ZZ; Zhang Z; Wu QG; Yu LW; Lai XP; Wan YH; Li G
    J Ethnopharmacol; 2016 Jan; 177():1-9. PubMed ID: 26571086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
    Hirsch KS; Jones CD; Audia JE; Andersson S; McQuaid L; Stamm NB; Neubauer BL; Pennington P; Toomey RE; Russell DW
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5277-81. PubMed ID: 8389478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors.
    Srivilai J; Minale G; Scholfield CN; Ingkaninan K
    Assay Drug Dev Technol; 2019; 17(2):44-57. PubMed ID: 30575417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride.
    Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP
    Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid sulfatase in the human hair follicle concentrates in the dermal papilla.
    Hoffmann R; Rot A; Niiyama S; Billich A
    J Invest Dermatol; 2001 Dec; 117(6):1342-8. PubMed ID: 11886493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit.
    Courchay G; Boyera N; Bernard BA; Mahe Y
    Skin Pharmacol; 1996; 9(3):169-76. PubMed ID: 8737913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism based representation of the active site of 5 alpha-reductase (5AR).
    Ahmed S; Denison S
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2615-70. PubMed ID: 9873591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.